Table 2.
Parameters | Patient no. 1 | Patient no. 2 | ||||||
---|---|---|---|---|---|---|---|---|
First incident | Second incident | First incident | Second incident | |||||
PRE | PERI | PRE | PERI | PRE | PERI | PRE | PERI | |
IgE (IU/mL) | 342 | 1,780 | 286 | 2,180 | 308 | 2,364 | 352 | 2,586 |
IgG (g/L) | 11.6 | 15.2 | 13.4 | 31.8 | 12.8 | 24.6 | 13.4 | 28.3 |
IgG1 (g/L) | 10.2346 | 14.5711 | 11.2671 | 23.1284 | 9.0153 | 32.5234 | 11.2 | 28.1247 |
IL-4 (ng/L) | 432.148 | 496.156 | 428.751 | 463.269 | 400.216 | 461.622 | 398.763 | 486.366 |
IL-10 (pg/mL) | 32.1482 | 149.123 | 28.5642 | 129.37 | 48.5342 | 214.157 | 41.2346 | 198.245 |
INF-γ (ng/L) | 135.166 | 98.3254 | 112.357 | 124.655 | 121.698 | 75.3326 | 110.325 | 158.987 |
TNF-α (μg/mL) | 0.1328 | 24.7868 | 2.1583 | 43.2866 | 9.2143 | 23.1563 | 12.9861 | 25.1476 |
Histamine (μg/L) | 17.83 | 34.96 | 17.88 | 37.2 | 18.09 | 34.18 | 17.24 | 26.25 |
PAF (μg/L) | 32.2 | 353.6 | 28.7 | 296.3 | 45.3 | 305.4 | 36.7 | 312.6 |
TXB2 (μg/L) | 123.8 | 213.6 | 151.4 | 235.1 | 140.5 | 262.4 | 138.7 | 255.8 |
IL = interleukin; INF-γ = interferon gamma; PAF = platelet-activating factor; PERI = perioperative levels; PRE = preoperative levels; TNF-α = tumor necrosis factor alpha; TXB2 = thromboxane B2.